NEWS AND EVENTS

The European Medicines Agency (EMA) has assessed the risk of nitrosamine formation or presence durin...

On October 31st , the Swiss Medicines Inspectorate published a technical interpretation of GMP Annex...

The European Medicines Agency (EMA) has revealed a new mechanism to combat critical medicine shortag...

The European Medicines Agency (EMA) has recently published the Guideline on quality, safety, efficac...

The European Medicines Agency (EMA) has recently updated its transparency rules regarding the public...

Brussels, 25 September 2023 - In a landmark move to protect the environment and human health, the Eu...

Article discuses progress in implementing web-based Human variations electronic Application Forms (e...

Over the past three years, the European Medicines Agency (EMA) and the European Network for Health T...

In the dynamic world of clinical trials, staying up to date with the latest regulations and tools is...

The European Commission, the Heads of Medicines Agency, and the European Medicines Agency have launc...

Non-Clinical Working Party (NcWP) is a dedicated group of European experts who operate under the umb...

The European Medicines Agency (EMA) is actively seeking new data partners with its new data analytic...

The Committee on Herbal Medicinal Products (HMPC) published a new Concept Paper on August 17, 2023, ...

Topiramate‑containing medicines are used in the EU for the treatment of epilepsy and prevention of...

One constant across the pharmaceutical industry is the requirement to keep dossiers updated and curr...

A significant aspect of ensuring the safety and efficacy of pharmaceutical products is the submissio...